It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Despite skyrocketing revenue from the sale of Covid-19 vaccines, shares of Pfizer plunged Tuesday morning after the pharmaceutical giant issued worse-than-expected revenue guidance for this year, triggering a widespread plunge among vaccine stocks that have struggled to meet analyst expectations as the pandemic begins to wane.
KEY FACTS
Pfizer shares fell more than 6% to $50 Tuesday morning, wiping out $19 billion in market value following an earnings report that beat analyst expectations with $3.4 billion in fourth-quarter profit (up fourfold year over year), but fell short of revenue projections, pulling in $23.8 billion, compared to average expectations calling for $24.1 billion.
In a Tuesday morning email, analyst Adam Crisafulli of Vital Knowledge Media pointed out the “underwhelming” report also issued worse-than-expected guidance for sales of Covid-19 vaccines, which made up 53% of the firm’s fourth-quarter revenue, with Pfizer now calling for $52 billion in revenue from the shots this year, compared to expectations of $58 billion.
Other Covid vaccine makers also fell sharply after the report, with shares of Pfizer partner Bio-N-Tech and competitor Moderna, which itself has struggled from disappointing projections, plunging 9% and 7%, respectively, erasing nearly $9 billion in combined market value.
Despite the plunge, Pfizer CEO Adam Bourla praised the firm’s “watershed” results during a Tuesday morning earnings call and pointed out expected overall revenue of about $100 billion next year would be a record high for the 173-year-old company.
edit on Tue Feb 8 2022 by DontTreadOnMe because: attempt to fix link
originally posted by: butcherguy
I thought Pfizer was guaranteed income with their agreement?
Plus they have the government coercing people to take the jab and jab their little kids.